Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants

Clinical trial NCT00289185 · COMPLETED

Trial details

NCT number: NCT00289185
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malaria Malaria Vaccines

Start date: 2006-09-27
Primary completion: 2008-02-11
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.